View by Year:
Select Year View All 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Gustin JA, Korgaonkar CK, Pincheira R, Li Q, Donner DB
Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52.
The Journal of biological chemistry , Jun-16-2006;281(24):16473-81. Epub 2006 Apr 12.
Jackson MW, Patt LE, LaRusch GA, Donner DB, Stark GR, Mayo LD
Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cells.
The Journal of biological chemistry , Jun-16-2006;281(24):16814-20. Epub 2006 Apr 18.
Schmidt NW, Mayo LD, Donner DB, Kaplan MH
p53 regulates Btk-dependent B cell proliferation but not differentiation.
Journal of leukocyte biology , Apr-2006;79(4):852-9. Epub 2006 Feb 3.
Matei D, Emerson RE, Lai YC, Baldridge LA, Rao J, Yiannoutsos C, Donner DD
Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.
Oncogene , Mar-30-2006;25(14):2060-9.
Srirangam A, Mitra R, Wang M, Gorski JC, Badve S, Baldridge L, Hamilton J, Kishimoto H, Hawes J, Li L, Orschell CM, Srour EF, Blum JS, Donner D, Sledge GW, Nakshatri H, Potter DA
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research , Mar-15-2006;12(6):1883-96.
Mayo LD, Seo YR, Jackson MW, Smith ML, Rivera Guzman J, Korgaonkar CK, Donner DB
Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
The Journal of biological chemistry , Jul-15-2005;280(28):25953-9. Epub 2005 Apr 20.
Nakakura EK, Sriuranpong VR, Kunnimalaiyaan M, Hsiao EC, Schuebel KE, Borges MW, Jin N, Collins BJ, Nelkin BD, Chen H, Ball DW
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.
The Journal of clinical endocrinology and metabolism , Jul-2005;90(7):4350-6. Epub 2005 May 3.
Arvold ND, Guha N, Wang D, Matli M, Deen DF, Warren RS, Haas-Kogan DA
Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro.
International journal of radiation oncology, biology, physics , May-1-2005;62(1):207-12.
Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM
Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research , Mar-1-2005;11(5):1791-7.
Toussaint-Smith E, Donner DB, Roman A
Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
Oncogene , Apr-15-2004;23(17):2988-95.
Gustin JA, Pincheira R, Mayo LD, Ozes ON, Kessler KM, Baerwald MR, Korgaonkar CK, Donner DB
Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells.
American journal of physiology. Cell physiology , Mar-2004;286(3):C547-55.
Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB
Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation.
The Journal of biological chemistry , Jan-16-2004;279(3):1615-20.
Su JD, Mayo LD, Donner DB, Durden DL
PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment.
Cancer research , Jul-1-2003;63(13):3585-92.
Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Cancer research , Jun-15-2003;63(12):3145-53.
Mayo LD, Donner DB
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
Trends in biochemical sciences , Sep-2002;27(9):462-7.
